Breast Cancer
-
Ultrasound imaging of breast cancer tumors offers non-invasive monitoring of radiation and immunotherapy response effectiveness
In the ongoing battle against triple negative breast cancer, Vanderbilt researchers have uncovered a promising non-invasive method to track how tumors respond to radiation and immunotherapy, which uses the body’s own immune system to fight cancer. While immunotherapy offers hope, many patients do not respond to current treatments. The primary… Read MoreJan. 28, 2025
-
In aggressive form of breast cancer, response to therapy may contribute to tumor regrowth, according to Vanderbilt-led study
In the ongoing battle against triple negative breast cancer, Vanderbilt researchers have uncovered a promising non-invasive method to track how tumors respond to radiation and immunotherapy, which uses the body’s own immune system to fight cancer. While immunotherapy offers hope, many patients do not respond to current treatments. The primary… Read MoreNov. 14, 2024
-
Rafat receives Young Investigator Grant from Breast Cancer Alliance
In the ongoing battle against triple negative breast cancer, Vanderbilt researchers have uncovered a promising non-invasive method to track how tumors respond to radiation and immunotherapy, which uses the body’s own immune system to fight cancer. While immunotherapy offers hope, many patients do not respond to current treatments. The primary… Read MoreFeb. 19, 2020
-
Research team documents potential new treatment path for breast cancer
In the ongoing battle against triple negative breast cancer, Vanderbilt researchers have uncovered a promising non-invasive method to track how tumors respond to radiation and immunotherapy, which uses the body’s own immune system to fight cancer. While immunotherapy offers hope, many patients do not respond to current treatments. The primary… Read MoreJan. 13, 2019
-
Novel, ‘multiplexed’ diagnosis may better identify candidates for cancer immunotherapy
In the ongoing battle against triple negative breast cancer, Vanderbilt researchers have uncovered a promising non-invasive method to track how tumors respond to radiation and immunotherapy, which uses the body’s own immune system to fight cancer. While immunotherapy offers hope, many patients do not respond to current treatments. The primary… Read MoreAug. 26, 2018
-
Collaborative efforts attract Stanford chemical engineer to Vanderbilt
In the ongoing battle against triple negative breast cancer, Vanderbilt researchers have uncovered a promising non-invasive method to track how tumors respond to radiation and immunotherapy, which uses the body’s own immune system to fight cancer. While immunotherapy offers hope, many patients do not respond to current treatments. The primary… Read MoreOct. 20, 2017
-
Postdoctoral fellow earns Susan G. Komen grant to prevent breast cancer recurrence
In the ongoing battle against triple negative breast cancer, Vanderbilt researchers have uncovered a promising non-invasive method to track how tumors respond to radiation and immunotherapy, which uses the body’s own immune system to fight cancer. While immunotherapy offers hope, many patients do not respond to current treatments. The primary… Read MoreNov. 9, 2016
-
Improving breast cancer chemo by testing tumors in a dish
In the ongoing battle against triple negative breast cancer, Vanderbilt researchers have uncovered a promising non-invasive method to track how tumors respond to radiation and immunotherapy, which uses the body’s own immune system to fight cancer. While immunotherapy offers hope, many patients do not respond to current treatments. The primary… Read MoreOct. 28, 2014
-
New technique tracks breast cancer subtypes, treatment effectiveness
In the ongoing battle against triple negative breast cancer, Vanderbilt researchers have uncovered a promising non-invasive method to track how tumors respond to radiation and immunotherapy, which uses the body’s own immune system to fight cancer. While immunotherapy offers hope, many patients do not respond to current treatments. The primary… Read MoreOct. 21, 2013